ACOG: Hormone therapy not recommended to prevent CHD

May 24, 2013
ACOG: hormone therapy not recommended to prevent CHD
Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists published in the June issue of Obstetrics & Gynecology.

(HealthDay)—Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists (ACOG) published in the June issue of Obstetrics & Gynecology.

The ACOG Committee on Gynecologic Practice conducted a review of current literature to update gynecologic practice recommendations relating to hormone therapy and .

The authors report that, at the present time, menopause hormone therapy should not be used for the primary or secondary prevention of . There is currently insufficient evidence to conclude that long-term estrogen therapy or hormone therapy use improves cardiovascular outcomes. Based on recent evidence, women with good cardiovascular health in early menopause should be considered candidates for the use of estrogen therapy or conjugated equine estrogen plus a progestin for relief of menopausal symptoms. Some evidence supports the "timing hypothesis," which suggests that cardiovascular benefit may be derived when estrogen therapy or hormone therapy is used close to the onset of menopause. Further research is needed to clarify the correlation between duration of therapy with cardiovascular outcomes. To reduce cardiovascular risk in menopausal women, heart-healthy lifestyles and other strategies should be encouraged.

"As with younger women, use of and should be individualized based on each woman's risk-benefit ratio and clinical presentation," the authors write.

More information: Full Text

Related Stories

Panel rules against HRT for preventing chronic disease

October 22, 2012

(HealthDay)—Postmenopausal women should not use hormone replacement therapy to prevent chronic medical conditions such as heart disease, according to updated recommendations from the U.S. Preventive Services Task Force.

Metabolic syndrome makes a difference in hormone therapy risk

October 30, 2012

A new analysis of the Women's Health Initiative (WHI) trials show that women who had metabolic syndrome before they started hormone therapy had a greatly increased risk of heart attack or dying of heart disease. Women who ...

Estrogen helps keep joint pain at bay after hysterectomy

March 20, 2013

Estrogen therapy can help keep joint pain at bay after menopause for women who have had a hysterectomy. Joint pain was modestly, but significantly, lower in women who took estrogen alone than in women who took placebo in ...

Recommended for you

Does mom's cellphone startle the fetus?

May 6, 2015

(HealthDay)—The sounds emitted by cellphones carried by pregnant women may rattle the sleep-and-wake cycles of their fetuses, new research suggests.

New IVF device may improve fertility treatment

April 28, 2015

For couples struggling to conceive the old-fashioned way, in vitro fertilization (IVF) provides an alternate route to starting a family. When eggs are mixed with sperm in test tubes, the fertilized eggs to grow into embryos ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.